TECHNICAL REPORT Options for the use of rapid antigen tests for COVID-19
14
36. Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, et al. Evaluation of rapid antigen test for detection
of SARS-CoV-2 virus. J Clin Virol. 2020;129:104500-.
37. Foundation for Innovative New Diagnostics (FIND). FIND Evaluation of RapiGEN Inc. BIOCREDIT COVID-19
Ag. External Report Version 1.0, 16 October 2020. Geneva: FIND; 2020 [cited 26 October 2020]. Available
from:
https://www.finddx.org/wp-content/uploads/2020/10/Rapigen_Ag-INTERIM-Public-Report_20201016-
v1.pdf
38. Shenzhen Bioeasy Biotechnology. BIOEASY Novel coronavirus (2019-nCoV) test kits. Shenzhen, Guangdong
Province, China: Shenzhen Bioeasy Biotechnology; 2020 [cited 26 October 2020]. Available from:
http://en.bioeasy.com/?page_id=1002
39. Krüger LJ, Gaeddert M, Köppel L, Brümmer LE, Gottschalk C, Miranda IB, et al. Evaluation of the accuracy,
ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for
<em>SARS-CoV-2</em>. medRxiv. 2020:2020.10.01.20203836.
40. Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, et al. Evaluation of a novel antigen-based
rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020;99:328-33.
41. CORIS Bioconcept. COVID-19 Ag Respi-Strip. CorisBioconcept SPRL; 2020 [cited 26 October 2020].
Available from: https://www.corisbio.com/Products/Human-Field/Covid-19.php#
42. Mertens P, De Vos N, Martiny D, Jassoy C, Mirazimi A, Cuypers L, et al. Development and Potential
Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context. Frontiers in medicine.
2020;7:225.
43. Lambert-Niclot S, Cuffel A, Le Pape S, Vauloup-Fellous C, Morand-Joubert L, Roque-Afonso A-M, et al.
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
Journal of clinical microbiology. 2020;58(8):e00977-20.
44. Blairon L, Wilmet A, Beukinga I, Tré-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a
laboratory without access to molecular methods: Experiences of a general hospital. Journal of Clinical
Virology. 2020;129:104472.
45. Veyrenche N, Bollore K, Pisoni A, Bedin A-S, Mondain A-M, Ducos J, et al. Diagnosis value of SARS-CoV-2
antigen/antibody combined testing using rapid diagnostic tests at hospital admission. medRxiv.
2020:2020.09.19.20197855.
46. Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H. Low
performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. Journal of Clinical
Virology. 2020;129:104455.
47. Foundation for Innovative New Diagnostics (FIND). FIND Evaluation of Coris BioConcept COVID-19 Ag
Respi-Strip. External Report Version 1.0, 18 September 2020. Geneva: FIND; 2020 [cited 26 October 2020].
Available from:
https://www.finddx.org/wp-content/uploads/2020/09/Coris-RespiStrip-Ag_Public-
Report_20200918.pdf
48. Fujirebio. Lumipulse® G SARS-CoV-2 Ag. Fujirebio; 2020 [cited 26 October 2020]. Available from:
https://www.fujirebio.com/en/products-solutions/lumipulse-g-sars-cov2-ag
49. Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, et al. Comparison of automated
SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs
including from 7 serially followed patients. Int J Infect Dis. 2020.
50. Abbott. PANBIO™ COVID-19 Ag rapid test device. Abbott; 2020 [cited 26 October 2020]. Available from:
https://www.globalpointofcare.abbott/en/product-details/panbio-covid-19-ag-antigen-test.html
51. Albert E, Torres I, Bueno F, Huntley D, Moya E, Fernandez-Funtes MA, et al. Field evaluation of a rapid
antigen test (Panbio COVID-19 Ag Rapid Test Device) for the diagnosis of COVID-19 in primary healthcare
centers. medRxiv. 2020:2020.10.16.20213850.
52. Gremmels H, Winkel BMF, Schuurman R, Rosingh A, Rigter NAM, Rodriguez O, et al. Real-life validation of
the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of
potential SARS-CoV-2 infection. medRxiv. 2020:2020.10.16.20214189.
53. Linares M, Pérez Tanoira R, Romanyk J, Pérez García F, Gómez-Herruz P, Arroyo T, et al. Panbio antigen
rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
medRxiv. 2020:2020.09.20.20198192.
54. SD BIOSENSOR. SD BIOSENSOR. SD BIOSENSOR; 2020 [cited 26 October 2020]. Available from:
http://www.sdbiosensor.com/xe
55. ROCHE. Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast
triage decisions at point of care. Basel: F. Hoffmann-La Roche Ltd; 2020 [cited 26 October 2020]. Available
from: https://www.roche.com/media/releases/med-cor-2020-09-01b.htm
56. Cerutti F, Burdino E, Milia MG, Allice T, Gregori G, Bruzzone B, et al. Urgent need of rapid tests for SARS
CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J Clin Virol.
2020;132:104654.
57. Liotti FM, Menchinelli G, Lalle E, Palucci I, Marchetti S, Colavita F, et al. Performance of a novel diagnostic
assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clin Microbiol Infect. 2020:S1198-
743X(20)30583-8.
58. Quidel Corporation. Sofia SARS Antigen FIA. Quidel Corporation; 2020. Available from:
https://www.quidel.com/immunoassays/rapid-sars-tests/sofia-sars-antigen-fia